Frank Ivy Carroll

Frank Ivy Carroll

Auto-generated profile, based on publicly available information

Frank Ivy Carroll

Research Triangle Institute , P.O. Box 12194, Research Triangle Park , North Carolina 27709 , United States

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FCF. Ivy Carroll
F. Ivy Carroll
BBBruce E. Blough
Bruce E. Blough
PAPhilip Abraham
Philip Abraham
AMAndrew C. Mills
Andrew C. Mills
JHJ. Ashley Holleman
J. Ashley Holleman
MFMichael J. Forster
Michael J. Forster

29 January 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FCF. Ivy Carroll
F. Ivy Carroll
WCWilliam A. Carlezon
William A. Carlezon

2 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
TCTao Che/Washington Che
Tao Che/Washington Che
JEJustin English
Justin English
BKBrian E. Krumm
Brian E. Krumm
KKKuglae Kim
Kuglae Kim
EPEls Pardon
Els Pardon
BRBryan L. Roth
Bryan L. Roth
Recent studies show that GPCRs rapidly interconvert between multiple states although our ability to interrogate, monitor and visualize them is limited by a relative lack of suitable tools. We previously reported two nanobodies (Nb39 and Nb6) that stabilize distinct ligand- and efficacy-delimited conformations of the kappa opioid receptor. Here, we demonstrate via X-ray crystallography a nanobody-targeted allosteric binding site by which Nb6 stabilizes a ligand-dependent inactive state. As Nb39 stabilizes an active-like state, we show how these two state-dependent nanobodies can provide real-time reporting of ligand stabilized states in cells in situ. Significantly, we demonstrate that chimeric GPCRs can be created with engineered nanobody binding sites to report ligand-stabilized states. Our results provide both insights regarding potential mechanisms for allosterically modulating KOR with nanobodies and a tool for reporting the real-time, in situ dynamic range of GPCR activity.

17 November 2011 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
FCF. Ivy Carroll
F. Ivy Carroll
ALAnita H. Lewin
Anita H. Lewin
SMS. Wayne Mascarella
S. Wayne Mascarella
HSHerbert H. Seltzman
Herbert H. Seltzman
PRP. Anantha Reddy
P. Anantha Reddy

1 October 2004 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ICIvy Carroll
Ivy Carroll
JTJames B. Thomas
James B. Thomas
LDLinda A. Dykstra
Linda A. Dykstra
AGArthur L. Granger
Arthur L. Granger
RARichard M. Allen
Richard M. Allen
LHLouis S. Harris
Louis S. Harris

29 May 2012 in BMC Pharmacology
Verified
Journal Article
Open access
PDF file
TMThomas Munro
Thomas Munro
LBLoren M Berry
Loren M Berry
AVAshlee Van’t Veer
Ashlee Van’t Veer
CBCécile Béguin
Cécile Béguin
FCF Ivy Carroll
F Ivy Carroll
BCBruce Michael Cohen
Bruce Michael Cohen
Background Nor-BNI, GNTI and JDTic induce κ opioid antagonism that is delayed by hours and can persist for months. Other effects are transient. It has been proposed that these drugs may be slowly...